CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 1 filers reported holding CHEMOCENTRYX INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $19,453,000 | +1558.4% | 376,583 | +695.6% | 0.16% | +1381.8% |
| Q2 2022 | $1,173,000 | +329.7% | 47,331 | +531.1% | 0.01% | +450.0% |
| Q4 2021 | $273,000 | -78.7% | 7,500 | -90.0% | 0.00% | -84.6% |
| Q3 2021 | $1,283,000 | +60.8% | 75,000 | +414.7% | 0.01% | -13.3% |
| Q3 2020 | $798,000 | -35.0% | 14,571 | -31.7% | 0.02% | -6.2% |
| Q2 2020 | $1,228,000 | – | 21,322 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
| Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
| Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
| HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
| Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
| Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
| Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
| Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
| RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
| Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |